Profitability Ratios
| Ratio |
Value |
| GP Margin |
61.6% |
| EBIT Margin |
13.7% |
| EBITDA Margin |
26.9% |
| Operating Margin |
16.5% |
| Pretax Margin |
10.1% |
| Cont. Ops Margin |
8.6% |
| Net Margin |
8.6% |
| Bottom Line Margin |
8.6% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
1.98 |
| Quick Ratio |
1.10 |
| Solvency Ratio |
0.173 |
| Cash Ratio |
0.23 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
-1.26 |
| Forward PEG |
-1.26 |
| Price/Book |
1.40 |
| Price/Sales |
2.16 |
| Price/FCF |
12.09 |
| Price/Op Cash Flow |
10.49 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.3256 |
| Debt/Equity |
0.5918 |
| Debt/Capital |
0.3718 |
| Long-Term Debt/Capital |
0.3530 |
| Financial Leverage |
1.82 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
3.46 |
| Operating Cash Flow Ratio |
0.657 |
| Operating Cash Flow/Sales |
20.6% |
| Free Cash Flow/Operating Cash Flow |
86.8% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
2.38 |
| Interest Coverage |
4.6523 |
| Short-Term Operating Cash Flow Coverage |
2.89 |
| Operating Cash Flow Coverage |
0.23 |
| Capital Expenditure Coverage |
7.56 |
| Dividend + Capital Expenditure Coverage |
4.09 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
26.9853% |
| Dividend Yield |
1.0689% |
| Dividend Yield % |
1.0689% |
| Dividend Per Share |
0.9611 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
41.57 |
| EPS |
3.562 |
| Debt/Share |
39.4540 |
| Cash/Share |
2.99 |
| Book Value/Share |
64.17 |
| Tangible BV/Share |
-9.89 |
| Equity/Share |
64.17 |
| Operating Cash Flow/Share |
8.571 |
| Capital Expenditure/Share |
1.134 |
| FCF/Share |
7.437 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.849 |
| Earnings Before Tax/EBIT |
0.610 |
| Price/Fair Value |
1.40 |
| Debt/Market Cap |
0.4223 |
| Effective Tax Rate |
15.1% |
| Enterprise Value Multiple |
11.15 |
ZBH - Zimmer Biomet Holdings, Inc.